Stifel analyst Rick Wise raised the firm’s price target on Baxter to $56 from $54 and keeps a Buy rating on the shares ahead of the company’s Q2 report due on July 27. The firm argues that the stage is set positively for Baxter to “regress to the mean” fundamentally with possible early signs of more-consistent performance as well as several growth-accelerating and margin-improving catalysts.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BAX:
- Baxter price target raised, added to ‘Tactical Outperform’ list at Evercore ISI
- Baxter call volume above normal and directionally bullish
Questions or Comments about the article? Write to editor@tipranks.com